Bloomberg @business
AstraZeneca, valued at $140 billion, is the U.K.’s biggest drugmaker by market capitalization. Gilead, worth $96 billion at Friday’s close, is the creator of a drug that’s received U.S. approval for use with coronavirus patients https://t.co/36Qr8xgwao — PolitiTweet.org